Top compounds associated with response to NRDC


Feature Type Standardized
Nominal ANOVA
mRNA JQ-1:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.025 0.5
mRNA foretinib CTRPv2 pan-cancer AAC 0.026 0.5
mRNA dabrafenib GDSC1000 pan-cancer AAC 0.023 0.5
mRNA ETP-46464 CTRPv2 pan-cancer AAC 0.031 0.5
mRNA vorapaxar CTRPv2 pan-cancer AAC 0.027 0.5
mRNA AZ628 GDSC1000 pan-cancer AAC -0.038 0.5
mRNA VX-680 GDSC1000 pan-cancer AAC -0.04 0.5
mRNA tamatinib CTRPv2 pan-cancer AAC 0.026 0.5
mRNA salermide:PLX-4032 (12:1 mol/mol) CTRPv2 pan-cancer AAC -0.026 0.5
mRNA GSK2636771 CTRPv2 pan-cancer AAC 0.031 0.5
Download CSV